These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36851522)

  • 21. MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy.
    Hikichi M; Kidokoro M; Haraguchi T; Iba H; Shida H; Tahara H; Nakamura T
    Mol Ther; 2011 Jun; 19(6):1107-15. PubMed ID: 21386827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential and clinical translation of oncolytic measles viruses.
    Robinson S; Galanis E
    Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synergistic Effect of NF-κB Signaling Pathway Inhibitor and Oncolytic 
Measles Virus Vaccine Strain against Lung Cancer and Underlying Mechanisms].
    Xia M; Meng G; Dong J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):245-253. PubMed ID: 33775041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of measles virus oncolytic immunotherapy.
    Pidelaserra-Martí G; Engeland CE
    Cytokine Growth Factor Rev; 2020 Dec; 56():28-38. PubMed ID: 32660751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.
    Lal S; Raffel C
    Methods Mol Biol; 2022; 2423():165-177. PubMed ID: 34978698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.
    Delaunay T; Achard C; Boisgerault N; Grard M; Petithomme T; Chatelain C; Dutoit S; Blanquart C; Royer PJ; Minvielle S; Quetel L; Meiller C; Jean D; Fradin D; Bennouna J; Magnan A; Cellerin L; Tangy F; Grégoire M; Fonteneau JF
    J Thorac Oncol; 2020 May; 15(5):827-842. PubMed ID: 31945495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK Cell Effector Functions and Bystander Tumor Cell Killing in Immunovirotherapy.
    Floerchinger A; Engeland CE
    Methods Mol Biol; 2022; 2521():233-248. PubMed ID: 35733001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
    Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
    Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiency.
    Alizadeh R; Ghanei M; Arashkia A; Dorostkar R; Azadmanesh K
    Microb Pathog; 2019 Oct; 135():103631. PubMed ID: 31381964
    [No Abstract]   [Full Text] [Related]  

  • 30. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
    Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
    Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photocontrollable mononegaviruses.
    Tahara M; Takishima Y; Miyamoto S; Nakatsu Y; Someya K; Sato M; Tani K; Takeda M
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11587-11589. PubMed ID: 31138700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.
    Anesti AM; Simpson GR; Price T; Pandha HS; Coffin RS
    BMC Cancer; 2010 Sep; 10():486. PubMed ID: 20836854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells.
    Tai CJ; Liu CH; Pan YC; Wong SH; Tai CJ; Richardson CD; Lin LT
    Sci Rep; 2019 May; 9(1):6767. PubMed ID: 31043633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format.
    Brachtlova T; van Ginkel JW; Luinenburg MJ; de Menezes RX; Koppers-Lalic D; Pegtel DM; Dong W; de Gruijl TD; van Beusechem VW
    Mol Ther Oncolytics; 2020 Dec; 19():332-343. PubMed ID: 33335978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
    Nettelbeck DM; Leber MF; Altomonte J; Angelova A; Beil J; Berchtold S; Delic M; Eberle J; Ehrhardt A; Engeland CE; Fechner H; Geletneky K; Goepfert K; Holm PS; Kochanek S; Kreppel F; Krutzke L; Kühnel F; Lang KS; Marchini A; Moehler M; Mühlebach MD; Naumann U; Nawroth R; Nüesch J; Rommelaere J; Lauer UM; Ungerechts G
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses.
    Peng KW; Myers R; Greenslade A; Mader E; Greiner S; Federspiel MJ; Dispenzieri A; Russell SJ
    Gene Ther; 2013 Mar; 20(3):255-61. PubMed ID: 22476202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering oncolytic measles virus to circumvent the intracellular innate immune response.
    Haralambieva I; Iankov I; Hasegawa K; Harvey M; Russell SJ; Peng KW
    Mol Ther; 2007 Mar; 15(3):588-97. PubMed ID: 17245355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs and oncolytic viruses.
    Ruiz AJ; Russell SJ
    Curr Opin Virol; 2015 Aug; 13():40-8. PubMed ID: 25863717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.
    Jing Y; Tong C; Zhang J; Nakamura T; Iankov I; Russell SJ; Merchan JR
    Cancer Res; 2009 Feb; 69(4):1459-68. PubMed ID: 19208845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.